Facebook
Twitter
LinkedIn
ForwardSymposium Guide
Miami Cancer Institute Global Summit on Immunotherapies for Hematologic Malignancies, Sixth Annual
Friday-Saturday, March 7-8, 2025
Test
Quick Links
Claim CME/CE Credit
Option 1: Text the six-letter code provided at the end of each day's session to (754) 203-8885. You will receive a message confirming your attendance.
Option 2: Scan the QR code shown below with your mobile phone, and enter the six-letter code provided at the symposium to receive your credit.
Evaluation
Once you have claimed your CME/CE credit, you will receive a link to your daily evaluation form via email and SMS.
Presentations
Friday, March 7 - 6.25 Cat. 1
Saturday, March 8 - 3.75 Cat. 1
| 7:30 – 8:30 a.m. | Registration, Breakfast and Visit Exhibits |
| Novel Approaches to AML Therapies | |
| 8:30 – 8:50 a.m. | Antigen Specific T-cell Therapies - From Targeting Viruses to AML Catherine Bollard, M.D. |
| 8:50 – 9:10 a.m. | LYT-200, an Anti-Galectin-9 Antibody, for Treatment of AML/high-risk MDS Aleksandra Filipovic M.D. Ph.D. |
| 9:10 – 9:30 a.m. | Novel Approaches to Treat AML Relapse Post Allo SCT Guenther Koehne, M.D., Ph.D. |
| 9:30 – 9:50 a.m. | AI in Oncology TBD |
| 9:50 – 10:10 a.m. | Panel Discussion |
| 10:10 – 10:25 a.m. | Break and Visit Exhibits |
| 10:25 – 11:10 a.m. | Product Theater |
| Allogeneic Stem Cell Transplants | |
| 11:10 – 11:30 a.m. | Next Steps in Cancer Immunotherapy Marcel van den Brink, M.D., Ph.D. |
| 11:30 – 11:50 noon | Uncoupling GVL and GVH - Déjà Vu All Over Again? Robert Soiffer, M.D. |
| 11:50 – 12:20 p.m. | The Role of Haploidentical Transplants in 2025 Leo Luznik, M.D. |
| 12:20 – 12:40 p.m. | Novel Approaches to GVHD Prevention and Therapy Corey Cutler, M.D. |
| 12:40 – 1:10 p.m. | Panel Discussion |
| 1:10 – 1:15 p.m. | Closing Remarks and Adjourn |
NOTE: Schedule subject to change.
